The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents
EuroIntervention 2011;6:1053-1059.
Gilles Lemesle, MD; Rebecca Torguson, MPH; Laurent Bonello, MD; Axel de Labriolle, MD; Gabriel Maluenda, MD; Itsik Ben-Dor, MD; Sara D. Collins, MD; Asmir I. Syed, MD; Zhenyi Xue, MS; Lowell F. Satler, MD; Augusto D. Pichard, MD; Ron Waksman, MD*
Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, DC, USA
Aims: Clopidogrel discontinuation after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation has been reported to correlate with stent thrombosis. Whether the